PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2744), 1mg/mL

Produktübersicht

• Artikelname: PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2744), 1mg/mL
• Artikelnummer: BOT-BNUM2744-50
• Hersteller Artikelnummer: BNUM2744-50
• Alternativnummer: BOT-BNUM2744-50-50UL
• Hersteller: Biotium
• Kategorie: Antikörper
• Applikation: WB

Produktbeschreibung

Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B

Produkteigenschaften

• Konzentration: 1 mg/mL
• Puffer: PBS, no BSA, no azide
• Quelle: Animal